Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Vogt

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Human Mutation|December 23, 2011
Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cellsAngelika C Roehl, Tanja Mussotter, David N Cooper, et al.
Psychology & Health|November 7, 2023
A mixed-methods approach to understanding barriers and facilitators to healthy eating and exercise from five European countries: highlighting the roles of enjoyment, emotion and social engagementSarah Snuggs, Sophie Clot, Daniel Lamport, et al.
JMIR Human Factors|December 11, 2023
Unveiling Consumer Preferences and Intentions for Cocreated Features of a Combined Diet and Physical Activity App: Cross-Sectional Study in 4 European CountriesBahram Mahmoodi Kahriz, Sarah Snuggs, Anumeha Sah, et al.
Epigenetics|June 2, 2020
The curious case of Merkel cell carcinoma: epigenetic youth and lack of pluripotencyEmil Chteinberg, Julia Vogt, Julia Kolarova, et al.
British Journal of Haematology|January 26, 2019
Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphomaJulia Paczkowska, Natalia Soloch, Magdalena Bodnar, et al.
Human Mutation|July 28, 2012
Identification of recurrent type-2 NF1 microdeletions reveals a mitotic nonallelic homologous recombination hotspot underlying a human genomic disorderJulia Vogt, Tanja Mussotter, Kathrin Bengesser, et al.
Human Mutation|August 21, 2010
Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletionsAngelika C Roehl, Julia Vogt, Tanja Mussotter, et al.
Genome Biology|June 25, 2014
SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpointsJulia Vogt, Kathrin Bengesser, Kathleen B M Claes, et al.
The Journal of Pathology|March 4, 2025
The significance of PAX5 in Merkel cell carcinomaEmil Chteinberg, Julia Kolarova, Julia Vogt, et al.
Leukemia|May 20, 2025
Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivoFranziska Auer, Mina N F Morcos, Mikko Sipola, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Human Mutation|December 23, 2011
Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cellsAngelika C Roehl, Tanja Mussotter, David N Cooper, et al.
Psychology & Health|November 7, 2023
A mixed-methods approach to understanding barriers and facilitators to healthy eating and exercise from five European countries: highlighting the roles of enjoyment, emotion and social engagementSarah Snuggs, Sophie Clot, Daniel Lamport, et al.
JMIR Human Factors|December 11, 2023
Unveiling Consumer Preferences and Intentions for Cocreated Features of a Combined Diet and Physical Activity App: Cross-Sectional Study in 4 European CountriesBahram Mahmoodi Kahriz, Sarah Snuggs, Anumeha Sah, et al.
Epigenetics|June 2, 2020
The curious case of Merkel cell carcinoma: epigenetic youth and lack of pluripotencyEmil Chteinberg, Julia Vogt, Julia Kolarova, et al.
British Journal of Haematology|January 26, 2019
Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphomaJulia Paczkowska, Natalia Soloch, Magdalena Bodnar, et al.
Human Mutation|July 28, 2012
Identification of recurrent type-2 NF1 microdeletions reveals a mitotic nonallelic homologous recombination hotspot underlying a human genomic disorderJulia Vogt, Tanja Mussotter, Kathrin Bengesser, et al.
Human Mutation|August 21, 2010
Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletionsAngelika C Roehl, Julia Vogt, Tanja Mussotter, et al.
Genome Biology|June 25, 2014
SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpointsJulia Vogt, Kathrin Bengesser, Kathleen B M Claes, et al.
The Journal of Pathology|March 4, 2025
The significance of PAX5 in Merkel cell carcinomaEmil Chteinberg, Julia Kolarova, Julia Vogt, et al.
Leukemia|May 20, 2025
Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivoFranziska Auer, Mina N F Morcos, Mikko Sipola, et al.
Pageof 6